Curza
Nick Skene's work experience includes various roles in finance, corporate consulting, education, and business development.
In 1999, they started their career as an Investment Banking Analyst at Tucker Anthony Sutro and worked there until 2001.
From 2003 to 2004, Nick worked as a Business Development professional at 3form.
In 2005, they had a brief stint as an Associate at Citigroup Alternative Investments.
From 2009 to 2020, Nick served as a Franchisee at Sylvan Learning Center, overseeing the operations of the Salt Lake City branch.
Starting from 2010, Nick has worked as a Corporate Finance Consultant as a self-employed contractor.
Since 2018, they have been serving as the Vice President of Finance at Curza.
Nick Skene earned their Bachelor of Science degree in Finance from The Wharton School in 1999. Nick then went on to obtain their MBA from The Wharton School in 2006.
This person is not in any teams
Curza
Curza is a small-molecule therapeutics company that has developed several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. Curza’s lead program is a new class of broad spectrum antibiotics, focused on ESKAPE pathogens and drug-resistant Gram-negative bacteria. Inspired by a natural product, thisclass targets an unexploited binding site of the bacterial ribosome. With ever increasing reports of resistance to frontline therapies addressing Gram-negative bacteria, there is a critical need for new therapies and new therapies that work in new ways. However, very little can be found in the development pipeline. As a result, Curza’s compounds are addressing a major unmet medical need.